290 related articles for article (PubMed ID: 18619722)
1. A toxicogenomics approach for early assessment of potential non-genotoxic hepatocarcinogenicity of chemicals in rats.
Uehara T; Hirode M; Ono A; Kiyosawa N; Omura K; Shimizu T; Mizukawa Y; Miyagishima T; Nagao T; Urushidani T
Toxicology; 2008 Aug; 250(1):15-26. PubMed ID: 18619722
[TBL] [Abstract][Full Text] [Related]
2. Prediction model of potential hepatocarcinogenicity of rat hepatocarcinogens using a large-scale toxicogenomics database.
Uehara T; Minowa Y; Morikawa Y; Kondo C; Maruyama T; Kato I; Nakatsu N; Igarashi Y; Ono A; Hayashi H; Mitsumori K; Yamada H; Ohno Y; Urushidani T
Toxicol Appl Pharmacol; 2011 Sep; 255(3):297-306. PubMed ID: 21784091
[TBL] [Abstract][Full Text] [Related]
3. Comparison of hepatocarcinogen-induced gene expression profiles in conventional primary rat hepatocytes with in vivo rat liver.
Doktorova TY; Ellinger-Ziegelbauer H; Vinken M; Vanhaecke T; van Delft J; Kleinjans J; Ahr HJ; Rogiers V
Arch Toxicol; 2012 Sep; 86(9):1399-411. PubMed ID: 22484513
[TBL] [Abstract][Full Text] [Related]
4. Prediction of a carcinogenic potential of rat hepatocarcinogens using toxicogenomics analysis of short-term in vivo studies.
Ellinger-Ziegelbauer H; Gmuender H; Bandenburg A; Ahr HJ
Mutat Res; 2008 Jan; 637(1-2):23-39. PubMed ID: 17689568
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver.
Ellinger-Ziegelbauer H; Stuart B; Wahle B; Bomann W; Ahr HJ
Mutat Res; 2005 Aug; 575(1-2):61-84. PubMed ID: 15890375
[TBL] [Abstract][Full Text] [Related]
6. Toxicogenomics discrimination of potential hepatocarcinogenicity of non-genotoxic compounds in rat liver.
Yamada F; Sumida K; Uehara T; Morikawa Y; Yamada H; Urushidani T; Ohno Y
J Appl Toxicol; 2013 Nov; 33(11):1284-93. PubMed ID: 22806939
[TBL] [Abstract][Full Text] [Related]
7. Predictive toxicogenomics approaches reveal underlying molecular mechanisms of nongenotoxic carcinogenicity.
Nie AY; McMillian M; Parker JB; Leone A; Bryant S; Yieh L; Bittner A; Nelson J; Carmen A; Wan J; Lord PG
Mol Carcinog; 2006 Dec; 45(12):914-33. PubMed ID: 16921489
[TBL] [Abstract][Full Text] [Related]
8. Detection of initiating potential of non-genotoxic carcinogens in a two-stage hepatocarcinogenesis study in rats.
Omura K; Uehara T; Morikawa Y; Hayashi H; Mitsumori K; Minami K; Kanki M; Yamada H; Ono A; Urushidani T
J Toxicol Sci; 2014; 39(5):785-94. PubMed ID: 25242409
[TBL] [Abstract][Full Text] [Related]
9. Medium-term rat liver bioassay for rapid detection of carcinogens and modifiers of hepatocarcinogenesis.
Ito N; Hasegawa R; Imaida K; Takahashi S; Shirai T
Drug Metab Rev; 1994; 26(1-2):431-42. PubMed ID: 8082578
[TBL] [Abstract][Full Text] [Related]
10. Characteristic expression profiles induced by genotoxic carcinogens in rat liver.
Ellinger-Ziegelbauer H; Stuart B; Wahle B; Bomann W; Ahr HJ
Toxicol Sci; 2004 Jan; 77(1):19-34. PubMed ID: 14600272
[TBL] [Abstract][Full Text] [Related]
11. Differential gene expression profiling between genotoxic and non-genotoxic hepatocarcinogens in young rat liver determined by quantitative real-time PCR and principal component analysis.
Suenaga K; Takasawa H; Watanabe T; Wako Y; Suzuki T; Hamada S; Furihata C
Mutat Res; 2013 Feb; 751(1):73-83. PubMed ID: 23183053
[TBL] [Abstract][Full Text] [Related]
12. Prediction of non-genotoxic carcinogenesis in rats using changes in gene expression following acute dosing.
Nioi P; Pardo ID; Sherratt PJ; Snyder RD
Chem Biol Interact; 2008 Apr; 172(3):206-15. PubMed ID: 18328469
[TBL] [Abstract][Full Text] [Related]
13. Development and evaluation of a genomic signature for the prediction and mechanistic assessment of nongenotoxic hepatocarcinogens in the rat.
Fielden MR; Adai A; Dunn RT; Olaharski A; Searfoss G; Sina J; Aubrecht J; Boitier E; Nioi P; Auerbach S; Jacobson-Kram D; Raghavan N; Yang Y; Kincaid A; Sherlock J; Chen SJ; Car B;
Toxicol Sci; 2011 Nov; 124(1):54-74. PubMed ID: 21813463
[TBL] [Abstract][Full Text] [Related]
14. Toxicogenomics and cancer risk assessment: a framework for key event analysis and dose-response assessment for nongenotoxic carcinogens.
Bercu JP; Jolly RA; Flagella KM; Baker TK; Romero P; Stevens JL
Regul Toxicol Pharmacol; 2010 Dec; 58(3):369-81. PubMed ID: 20801182
[TBL] [Abstract][Full Text] [Related]
15. Cross-platform toxicogenomics for the prediction of non-genotoxic hepatocarcinogenesis in rat.
Römer M; Eichner J; Metzger U; Templin MF; Plummer S; Ellinger-Ziegelbauer H; Zell A
PLoS One; 2014; 9(5):e97640. PubMed ID: 24830643
[TBL] [Abstract][Full Text] [Related]
16. An improved model of predicting hepatocarcinogenic potential in rats by using gene expression data.
Yamada F; Sumida K; Saito K
J Appl Toxicol; 2016 Feb; 36(2):296-308. PubMed ID: 26198598
[TBL] [Abstract][Full Text] [Related]
17. Differences in gene expression profiles in the liver between carcinogenic and non-carcinogenic isomers of compounds given to rats in a 28-day repeat-dose toxicity study.
Nakayama K; Kawano Y; Kawakami Y; Moriwaki N; Sekijima M; Otsuka M; Yakabe Y; Miyaura H; Saito K; Sumida K; Shirai T
Toxicol Appl Pharmacol; 2006 Dec; 217(3):299-307. PubMed ID: 17070881
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of predictive models for nongenotoxic hepatocarcinogenicity using both toxicogenomics and quantitative structure-activity relationships.
Liu Z; Kelly R; Fang H; Ding D; Tong W
Chem Res Toxicol; 2011 Jul; 24(7):1062-70. PubMed ID: 21627106
[TBL] [Abstract][Full Text] [Related]
19. Discrimination of genotoxic and non-genotoxic hepatocarcinogens by statistical analysis based on gene expression profiling in the mouse liver as determined by quantitative real-time PCR.
Watanabe T; Suzuki T; Natsume M; Nakajima M; Narumi K; Hamada S; Sakuma T; Koeda A; Oshida K; Miyamoto Y; Maeda A; Hirayama M; Sanada H; Honda H; Ohyama W; Okada E; Fujiishi Y; Sutou S; Tadakuma A; Ishikawa Y; Kido M; Minamiguchi R; Hanahara I; Furihata C
Mutat Res; 2012 Sep; 747(2):164-75. PubMed ID: 22634710
[TBL] [Abstract][Full Text] [Related]
20. A toxicogenomic approach for the prediction of murine hepatocarcinogenesis using ensemble feature selection.
Eichner J; Kossler N; Wrzodek C; Kalkuhl A; Bach Toft D; Ostenfeldt N; Richard V; Zell A
PLoS One; 2013; 8(9):e73938. PubMed ID: 24040119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
